“It is a single antigen vaccine. And for respiratory illnesses, the single antigen vaccines have never worked,” Kennedy said when asked by CBS’s chief medical correspondent, Jonathan ...

Helix BioPharma is a clinical-stage biopharmaceutical company aiming to turn scientific breakthroughs into real-world solutions for some of the most difficult-to-treat cancers.

1Department of Pathology, St. Jude Children’s Research Hospital, Memphis, Tennessee. Search for other works by this author on: 2Department of Computational Biology, St. Jude Children’s Research ...

Shuai Chen, MD https://orcid.org/0009-0007-8628-4313 Department of Neurology, The People’s Hospital of Zhengzhou University and Henan Provincial People’s Hospital ...

To date, the Food and Drug Administration (FDA) has approved seven chimeric antigen receptor-T (CAR-T) cell therapies and seven bispecific T-cell engagers (BiTEs) across a variety of hematologic ...

This subcellular compartment is where antigens are trimmed (generating an antigen version called an epitope) and loaded onto MHC-I molecules. For the antigen-attached molecule, the authors ...

Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, announced that the US Food and Drug ...

School of Medicine, South China University of Technology, Guangzhou, Guangdong 510006, P.R. China National Engineering Research Center for Tissue Restoration and Reconstruction, South China University ...

Despite being a picture of health, an AI-powered blood test in 2022 revealed that one of the world's deadliest cancers was ...

Pathological tumor stage (HR=1.336 [overall survival]/1.768 [progression-free survival], p<0.005), pathological lymph node stage (HR=1.665/1.433, p<0.005), carcinoembryonic antigen (CEA) ...

The objective of this study was to target synthetically glycosylated antigen to LN APCs to induce antigen-specific immunological tolerance, and investigate the ...